AXGN Q1 2018 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q1 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+41.0% YoY

Gross Profit

$15M84.3% margin

Operating Income

-$5M-28.9% margin

Net Income

-$6M-32.7% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$55M

Total Liabilities

$33M

Stockholders' Equity

$22M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$12M	+41.0%
Gross Profit	$15M	$10M	+40.9%
Operating Income	-$5M	-$3M	-56.0%
Net Income	-$6M	-$4M	-49.9%